4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
eXoZymes, Inc. (EXOZ) operates in the Biotechnology industry and is headquartered in Monrovia, United States with about 32 employees. Its market capitalization is roughly $67 million. In the fiscal year ended 2025-12-31, EXOZ reported $0M in revenue and ($9M) in net income.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($10M) | ($6M) | ($2M) | ($1M) | — |
| Net Income | ($9M) | ($6M) | ($2M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($2M) | ($3M) | ($2M) | ($2M) | ($2M) |
| Net Income | ($2M) | ($3M) | ($2M) | ($2M) | ($2M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $6M | $13M | $4M | $3M | — |
| Total Liabilities | $3M | $3M | $4M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EXOZ viewer.
About TickerBase · Data methodology & sources